#FukudaDenshi

On February 5, 2026, at Fukuda Lifetech Tokyo Co., Ltd., a delivery slip containing personal information was mistakenly sent, potentially leaking information of 550 patients. Deletion requests have been made.

For the third quarter of fiscal year ending March 2026, consolidated net sales were 98,857 million yen (0.5% year-over-year decrease), operating income was 16,400 million yen (5.7% year-over-year decrease), and net income attributable to owners of the parent was 11,726 million yen (5.2% year-over-year decrease).

Following the board resolution on January 26, 2026, a tender offer for treasury stock of 317,100 shares with an upper limit of JPY 2,131,229,100 will be conducted. The acquisition period is from January 27, 2026 to March 31, 2026.

Fukuda Denshi Co., Ltd. will absorb its wholly owned subsidiary, Fukuda Medical Solution Co., Ltd., effective April 1, 2026, to integrate the maintenance support system.